SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
UC San Diego is joining a multimillion-dollar research effort to better understand “microbiomes,” the White House announced. The area of science is a potential goldmine for drug discoveries, and collaborators hope advancing the research will have wide applications in human health.
Venture capital dipped slightly for San Diego companies, according to a first-quarter report from Cushman & Wakefield. The health care sectors, however, are still stealing the show.
San Diego’s biotech community was teeming with activity last week as corporations raised cash and made other strides toward getting products to market.
San Diego’s Imprimis Pharmaceuticals, a maker of compounded drugs, reported a big jump in revenue for the first quarter of 2016.
TP Therapeutics Inc., a small pharmaceutical company that just raised $18 million, is moving to a new facility in Torrey Ridge Science Center.
Sophiris Bio has hired Oppenheimer & Co. Inc. as its financial advisor to help the company boost shareholder value, the company said Thursday. The announcement comes days after the company said it would offer $5 million of its common stock to the public.
Two firms in San Diego County announced partnerships Thursday, one with tech giant IBM and the other with the University of California, Los Angeles.
MEDTECH: Devices Aim to Provide Seniors With Low-Cost Care
As aging baby boomers strain traditional health care resources, some local companies are taking the growing senior health technology space in a new direction: Treat at home, monitor at home, thrive at home.
Strategies for High-Growth Companies
San Diego is home to an incredible intersection of technology and science, which has produced a growing local economy of research, advanced wireless communication, medical devices, genomics and more.
BIOTECH: Cos. Swallow Up Startups But Grow Presence
The growing presence of Big Pharma and global life science firms in San Diego has been at the heart of an age-old debate: do they help or hurt the region’s economy?
Two San Diego life science companies reported earnings Tuesday afternoon, one missing Wall Street expectations and the other beating predictions.
DJO Global Inc., a medical device company based in Vista, announced its first quarter results, ending April 1.
Ending a months-long search for a new chief executive, San Diego’s Arena Pharmaceuticals Inc. announced Tuesday that it has appointed Amit D. Munshi as president, CEO, and interim principal financial officer.
San Diego drugmaker Otonomy Inc. reported financial earnings and a corporate update Monday.
San Diego-based biopharmaceutical company Apricus Biosciences Inc. reported total revenue of $626,000 for the first quarter of 2016, with a net loss of $2.5 million.